206 related articles for article (PubMed ID: 28780840)
21. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnosis of benign and malignant breast lesions using quantitative synthetic magnetic resonance imaging].
Zhang L; Zhao X; Yin X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):457-462. PubMed ID: 35527481
[TBL] [Abstract][Full Text] [Related]
23. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
Zhu YJ; Li Y; Jiang J; Zhang W; Xue LY; Zhou AP; Jiang LM
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):765-770. PubMed ID: 31648499
[No Abstract] [Full Text] [Related]
24. Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience.
Fusco R; Granata V; Mattace Raso M; Vallone P; De Rosa AP; Siani C; Di Bonito M; Petrillo A; Sansone M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067721
[TBL] [Abstract][Full Text] [Related]
25. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic mapping for lesion classification in dynamic breast MRI.
Schabel MC; Morrell GR; Oh KY; Walczak CA; Barlow RB; Neumayer LA
J Magn Reson Imaging; 2010 Jun; 31(6):1371-8. PubMed ID: 20512889
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
[TBL] [Abstract][Full Text] [Related]
28. Fractal Dimension Analysis of Pixel Dynamic Contrast Enhanced-Magnetic Resonance Imaging Pharmacokinetic Parameters for Discrimination of Benign and Malignant Breast Lesions.
Sherminie LPG; Jayatilake ML
JCO Clin Cancer Inform; 2023 Jan; 7():e2200101. PubMed ID: 36745858
[TBL] [Abstract][Full Text] [Related]
29. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
30. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
[TBL] [Abstract][Full Text] [Related]
31. Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET/MRI system in breast cancer: A feasibility study.
Jena A; Taneja S; Singh A; Negi P; Mehta SB; Sarin R
Eur J Radiol; 2017 Jan; 86():261-266. PubMed ID: 28027758
[TBL] [Abstract][Full Text] [Related]
32. Quantitative transport mapping (QTM) for differentiating benign and malignant breast lesion: Comparison with traditional kinetics modeling and semi-quantitative enhancement curve characteristics.
Zhang Q; Spincemaille P; Drotman M; Chen C; Eskreis-Winkler S; Huang W; Zhou L; Morgan J; Nguyen TD; Prince MR; Wang Y
Magn Reson Imaging; 2022 Feb; 86():86-93. PubMed ID: 34748928
[TBL] [Abstract][Full Text] [Related]
33. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
34. Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI.
Radjenovic A; Dall BJ; Ridgway JP; Smith MA
Br J Radiol; 2008 Feb; 81(962):120-8. PubMed ID: 18070824
[TBL] [Abstract][Full Text] [Related]
35. Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
Yu J; Xu Q; Huang DY; Song JC; Li Y; Xu LL; Shi HB
Eur Radiol; 2017 May; 27(5):1840-1847. PubMed ID: 27595835
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
[TBL] [Abstract][Full Text] [Related]
37. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.
Su MY; Yu HJ; Carpenter PM; McLaren CE; Nalcioglu O
Technol Cancer Res Treat; 2005 Jun; 4(3):255-63. PubMed ID: 15896081
[TBL] [Abstract][Full Text] [Related]
39. Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement.
Newell D; Nie K; Chen JH; Hsu CC; Yu HJ; Nalcioglu O; Su MY
Eur Radiol; 2010 Apr; 20(4):771-81. PubMed ID: 19789878
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions.
Veltman J; Stoutjesdijk M; Mann R; Huisman HJ; Barentsz JO; Blickman JG; Boetes C
Eur Radiol; 2008 Jun; 18(6):1123-33. PubMed ID: 18270714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
